Thursday, September 9, 2010
Special populations
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This article provides guidance on the management and treatment of acute pain in patients receiving buprenorphine/naloxone.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Logistics of buprenorphine treatment
- Addiction
- Dependence
- Discontinuation
- Dosing
- Induction
- Maintenance
- Methadone
- Pain
- Pharmacology
- Relapse
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
This information brief discusses the abuse of prescription drugs by young people, commonly abused prescription drugs, and diversion of said drugs.
Source:
National Drug Intelligence Center
Tags:
Description:
This guideline offers guidelines on treating pregnant, substance-using women, with sections on Alcohol and Other Drug Treatment Guidelines for Pregnant, Substance-Using Women, Medical Guidelines for Pregnant, Substance-Using Women, and Legal and Ethical Guidelines for the Care of Pregnant, Substance-Using Women.
Source:
U.S Department of Health and Human Services
Tags:
Description:
This guideline discusses management of psychiatric medications in patients receiving buprenorphine/naloxone, and answers the question "How do I manage medications for co-occurring psychiatric disorders in a patient receiving buprenorphine/naloxone (bup/nx) for the treatment of opioid dependence?"
Source:
PCSSmentor.com
Description:
This study largely focused on children of parents who abuse alcohol but also contains some information on children of drug users.
Source:
Johnson JL, Leff M.Children of substance abusers: overview of research findings. Pediatrics. 1999;103(suppl 5, pt 2):1085-1099.
Description:
A wealth of information from the CDC about the types of hepatitis viruses, including HBV and HCV.
Source:
Centers for Disease Control and Prevention (CDC)
Description:
Information from the CDC on prevention, detection, and epidemiology of HIV/AIDS, including fact sheets suitable for patients.
Source:
Centers for Disease Control and Prevention (CDC)
Tags:
Description:
This guide contains information for health care providers on the problem of drug-exposed infants and their families. Topics covered include medical management, followup and aftercare, psychosocial services, ethical and legal guidelines, and quality assurance.
Source:
Center for Substance Abuse Treatment (CSAT) 
